small molecule

DOVONEX

CALCIPOTRIENE

Loss of exclusivityloss of exclusivity
CompanyLEO PHARMA AS

Drug detail

Brand nameDOVONEX
Active ingredientCALCIPOTRIENE
Strength0.005%
Dosage formCREAM
RouteTOPICAL
ModalitySmall molecule
FDA approvalJuly 1996
Marketing statusRX

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

DOVONEX patent cliff — loss of exclusivity — | CliffBio